Labshake search
Citations for BioLegend :
101 - 150 of 3089 citations for Recombinant Human Lectin Galactoside Binding Soluble 3 since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2020Quote: ... and soluble anti-CD28 (2μg/mL) (BioLegend) antibodies for 24 hrs before 7575 live cells were sorted directly into lysis buffer ...
-
bioRxiv - Immunology 2020Quote: ... and soluble anti-CD28 (2μg/mL) (BioLegend) antibodies in RPMI (Merck) ...
-
bioRxiv - Immunology 2022Quote: ... 5 μg/ml soluble αCD28 mAb (BioLegend) plus 200 U/ml IL-2 (Miltenyi Biotec ...
-
bioRxiv - Bioengineering 2024Quote: ... and soluble anti-CD28 ((1μg/ml; Biolegend). The culture medium was supplemented with murine IL-2 (2ng/ml ...
-
bioRxiv - Immunology 2020Quote: ... Lectins were finally detected with FITC-conjugated streptavidin (Biolegend, 405201). Mouse joint sections (7 μm ...
-
bioRxiv - Bioengineering 2021Quote: ... such as the recombinant human matrix metalloproteinases 12 (MMP12, 1 μl, 20 ng/ml, Biolegend, U.S.A), MMP408 (the inhibitor of MMP12 ...
-
bioRxiv - Immunology 2022Quote: ... Monocytes were cultured in 10 ng/mL recombinant human GM-CSF or M-CSF (both Biolegend) for 7 days at 37°C ...
-
bioRxiv - Immunology 2022Quote: ... Monocytes were cultured in 10 ng/mL recombinant human GM-CSF or M-CSF (both Biolegend) for 7 days at 37°C ...
-
bioRxiv - Immunology 2020Quote: ... pooled from a minimum of four healthy human donors) and 50 ng/mL of recombinant human MΦ colony-stimulating factor (M-CSF) (Biolegend; San Diego, CA, USA). Monocytes were cultured in monocyte culture media at a cellular density of 1.5 x 106 cells/mL in 6-well cell culture plates ...
-
bioRxiv - Immunology 2020Quote: ... 3 μl of anti-human CD3-AF700 antibody (clone UCHT1, Biolegend) and 1 μl of anti-human CD14-PE antibody (clone 61D3 ...
-
bioRxiv - Immunology 2019Quote: ... Antibodies include mouse anti-human ataxin-3 65042 1H9-2 (BioLegend), mouse anti-human MIC60 ab110329 (Abcam) ...
-
bioRxiv - Immunology 2020Quote: ... Non-specific binding was blocked by incubating cells with human anti-Fc Receptor antibodies (TrueStain, Biolegend, Cat. No. 101320) or anti-mouse CD16/32 Fc block (Biolegend ...
-
bioRxiv - Cancer Biology 2019Quote: ... and cultured with 2μg/ml soluble αCD28 (Biolegend). The following conditions were specific to each differentiation regime ...
-
bioRxiv - Immunology 2022Quote: ... and the DAXL-88 (anti-AXL) binding assay used Alexa Fluor 647 AffiniPure anti-Fc tag Goat Anti-Human IgG (410711, BioLegend). Anti-Human CD4 antibody (BD ...
-
bioRxiv - Immunology 2020Quote: ... All binding assays were performed in AnV Binding Buffer (Biolegend, San Diego, CA). For competition experiments ...
-
bioRxiv - Immunology 2020Quote: ... and 3 μl of anti-human TCRab-AF488 antibody (clone IP26, Biolegend). After 2 washes in staining buffer (PBS containing 0.5% FBS and 2mM EDTA (pH 8.0) ...
-
bioRxiv - Immunology 2020Quote: ... and 3 μl of anti-human TCRab-AF488 antibody (clone IP26, Biolegend), as described in the flow cytometry section above ...
-
Linear ubiquitination at damaged lysosomes induces local NF-κB activation and controls cell survivalbioRxiv - Cell Biology 2023Quote: ... rat anti-mouse/human Galectin 3 (BioLegend Cat# 125402, RRID:AB_1134238, 1:100), rabbit anti-TAX1BP1 (Sigma-Aldrich Cat# HPA024432 ...
-
bioRxiv - Systems Biology 2020Quote: ... respective concentrations (ranging from 25 ng/mL to 100 ng/mL) of recombinant human IL-8 (Biolegend, 715404) and/or recombinant human CCL2 (Peprotech ...
-
bioRxiv - Cell Biology 2023Quote: ... 720-IC-200) or 1 μg/ml Fc-VCAM-1 (Recombinant Human VCAM-1-Fc Chimera, Biolegend, 553706) was added to the chamber slide ...
-
bioRxiv - Microbiology 2024Quote: ... Activation of MAPK and NF-κB signaling pathways was triggered using human recombinant TNF-α (BioLegend, Cat. 570102). Detailed information concerning experimental procedure is given in supplementary material.
-
bioRxiv - Cancer Biology 2024Quote: ... T cells were activated for 3 days using 3 μg anti-human CD3 and CD28 antibodies (Biolegend, 300438, 377604) and 50 ng/mL of IL-2 (Peprotech ...
-
bioRxiv - Immunology 2020Quote: ... and soluble anti-CD28 (37.51, BioLegend, 1 μg/mL) as indicated ...
-
bioRxiv - Immunology 2022Quote: ... and soluble α-CD28 (1 μg/mL; 37.51; BioLegend) or plate-bound α-CD3ε (2 μg/mL ...
-
bioRxiv - Immunology 2020Quote: ... and 5µg/ml of soluble anti-CD28 (302913, Biolegend). CTV-labelled T-cells cultured in medium only were an unstimulated control.
-
bioRxiv - Immunology 2022Quote: ... and soluble anti-CD28 (1µg/ml, clone 37.51, Biolegend) in the presence of rhIL-2 (50U/ml ...
-
bioRxiv - Immunology 2023Quote: ... in presence of soluble anti-CD28 (CD28.2; 302914; BioLegend) during 6 days prior to use and cultured in RPMI 1640 Glutamax (Fisher Scientific ...
-
bioRxiv - Molecular Biology 2023Quote: ... and soluble anti-CD28 antibody (2.5 µg/mL; BioLegend). Cells were transduced on RetroNectin (100 µg/mL ...
-
bioRxiv - Immunology 2023Quote: ... soluble mCD28 (0.5 µg ml-1, clone 37.51, Biolegend), rhIL-2 (50 Uml-1 ...
-
bioRxiv - Immunology 2023Quote: ... soluble αCD28 (Ultra LEAF© purified, clone 37.51, Biolegend) and 20U/ml recombinant murine interleukin 2 (rmIL-2 ...
-
bioRxiv - Immunology 2023Quote: ... THP-1 and SKOV-3 cell lines and primary human T cells were labeled with fluorescent antibody against human CD70 or isotype control (Biolegend) to verify antigen expression as described before35.
-
bioRxiv - Immunology 2022Quote: ... neutrophils were incubated with autologous activated platelets (1:10 ratio) (65) for 2.5h and human recombinant CCL28 (50 nM) (BioLegend), the CCR3 antagonist SB328437 (10 mM ...
-
bioRxiv - Cancer Biology 2022Quote: Cells cultured in 2D were seeded at 5 × 105 cells/well in 6-well plates and incubated with recombinant human interferon gamma (IFNγ) (0.5 ng/mL) (Biolegend) and/or recombinant tumour necrosis factor alpha (TNFα ...
-
bioRxiv - Immunology 2023Quote: ... Recombinant IFNα (Biolegend), TNFα (PeproTech) ...
-
bioRxiv - Microbiology 2023Quote: ... Nonspecific antigen binding to Fc receptors was inhibited via 10 minutes of blocking with Human TruStain FcX (BioLegend, San Diego, CA, USA). Cells were subsequently stained with mouse anti-human CD20 (Alexa-700) ...
-
bioRxiv - Immunology 2021Quote: ... soluble CD28 antibody added (clone CD28.2 at 0.5μg/mL) (BioLegend). Other activation types assessed include ...
-
bioRxiv - Immunology 2021Quote: ... 1 ug/ml soluble anti-CD28 antibody (BioLegend, LEAF grade) and 2 ng/ml IL-2 (carrier-free ...
-
bioRxiv - Immunology 2022Quote: ... and 1µg/ml soluble anti-mouse CD28 (Biolegend, Cat.102116) for different time points with or without addition of transporter block (Thermo Scientific ...
-
bioRxiv - Immunology 2022Quote: ... with soluble anti-CD28 (2 μg/mL) (ULTRA-LEAF Biolegend) in the presence or absence of a mouse anti-human PD1 (2 μg/mL ...
-
bioRxiv - Cell Biology 2024Quote: ... and 1 µg / ml soluble anti-CD28 (BioLegend, Cat. # 1002116). Cells were stained for live/dead cells ...
-
bioRxiv - Immunology 2022Quote: ... Frozen PBMC of post-CA patients were thawed and incubated in media (RPMI1640 + 2% FBS) with recombinant human Nectin-2 (Biolegend) or isotype control (ENZO ...
-
bioRxiv - Immunology 2022Quote: ... 5×104 B cells were first incubated with 5 µg/ml anti-IgM complexes and 1 µg/ml recombinant Human CD40L (Biolegend) for 30 mins and then 1×104 Tfr cells were added ...
-
bioRxiv - Physiology 2023Quote: ... zoledronic acid (Novartis Pharmaceuticals) and/or 50 μg/kg (i.p.) recombinant human granulocyte-colony stimulating factor (G-CSF; carrier-free, BioLegend #578604) for three days ...
-
bioRxiv - Immunology 2023Quote: ... 200 μl for 96-well plates) supplemented with 1 μg/ml of recombinant human B cell-activating factor (BAFF, BioLegend). 1 µg/ml rHA from H1N1 (PR8 ...
-
bioRxiv - Immunology 2024Quote: ... which is RPMI-1640-based and supplemented with 5 μg/mL recombinant mouse IL-3 (#575506 or #575508, BioLegend) as described in previous studies (6 ...
-
bioRxiv - Immunology 2023Quote: ... recombinant IFNα2 (#592702) and recombinant IFNγ (#570202) were obtained from BioLegend. PNGase F (#P0704S ...
-
bioRxiv - Immunology 2022Quote: ... tissue sections were blocked with 3% BSA and Human TruStain FcX (1:100, BioLegend) in PBST for 1 hour at room temperature ...
-
bioRxiv - Cell Biology 2022Quote: ... or alternatively with Brilliant Violet 421 anti-mouse/human Galectin-3 antibody (125416, Biolegend) for 30 min at RT ...
-
bioRxiv - Microbiology 2021Quote: ... in Annexin V binding buffer (BioLegend) containing 50 U/mL hirudin for 20 min (RT ...
-
bioRxiv - Cancer Biology 2022Quote: ... in Annexin V binding buffer (Biolegend) for 30 minutes at room temperature ...